3,449
Views
0
CrossRef citations to date
0
Altmetric
Original Articles

Gastro-oesophageal reflux disease: The Montreal definition and classification

, MBChB, FCP (Private Gastroenterologist) (President) (Private Gastroenterologist) (President)
Pages 19-26 | Published online: 15 Aug 2014

References

  • Vakil N, Van Zanten Z, Kahrilas P et al. The Montreal definition and classification of gastroesophageal reflux disease: A global evidence-based consensus. Am J Gastroenterol 2006; 101: 1900–20.
  • Klauser AG, Schindlebek NE, Muller-Lissner SA. Symptoms in gastro-oesophageal reflux disease. Lancet 1990; 335: 205–208.
  • Revicki DA, Wood M, Wiklund I et al. The impact of gastro-oesophageal disease on health-related quality of life. Am J Med 1998; 104: 252–8.
  • Jones RH, Hungin APS, Phillips J et al. Gastro-oesophageal reflux disease in primary care in Europe: Clinical presentation and endoscopic findings. Eur J Gen Pract 1995; 1: 149–54.
  • Van Pinxteren B, Numan ME, Bonis PA et al. Short-term treatment with proton pump inhibitors, H2-receptor antagonists and prokinetics for gastro-oesophageal reflux disease-like symptoms and endoscopy negative reflux disease. Cochrane Database Syst Rev 2004; (4): CD002095.
  • Tack J, Koek G, Demedts I et al. Gastro-esophageal reflux disease poorly responsive to single-dose proton pump inhibitors in patients without Barrett's oesophagus: Acid reflux, bile reflux or both? Am J Gastroenterol 2004; 99: 981–8.
  • Kawamura O, Aslam M, Rittman T et al. Physical and pH properties of gastroesophago-pharyngeal refluxate: A 24-hour simultaneous ambulatory impedance and pH monitoring study. Am J Gastroenterol 2004; 99: 1000–10.
  • Vakil N, Katz P, Traxler B et al. Resolution of epigastric pain accompanies resolution of heartburn in endoscopy-negative GERD. Gastroenterol 2003; 124: A–542.
  • Fass R, Quan SF, O'Connor GT et al. Predictors of heartburn during sleep in a large prospective cohort study. Chest 2005; 127: 1658–66.
  • Eslick GD, Jones M, Talley NJ. Non-cardiac chest pain: Prevalence, risk-factors, impact and consulting a population-based study. Aliment Pharmacol Ther 2003; 17: 1115–24.
  • Nandurkar S, Talley NJ, Martin CJ et al. Esophageal histology does not provide additional useful information over clinical assessment in identifying reflux patients presenting for esophagogastroduodenoscopy. Dig Dis Sci 2000; 45: 217–24.
  • El-Serag HB, Johanson JF. Risk factors for the severity of erosive esophagitis in Helicobacter pylori-negative patients with gastro-esophageal reflux disease. Scand J Gastroenterol 2002; 37: 899–904.
  • Vakil NB, Traxler B, Levine D. Dysphagia in patients with erosive esophagitis: Prevalence, severity, and response to proton pump inhibitor treatment. Clin Gastroenterol Hepatol 2004; 2: 665–8.
  • Kapoor N, Bassi A, Sturgess R et al. Predictive value of alarm features in a rapid access upper gastrointestinal cancer service. Gut 2005; 54: 40–5.
  • Locke GR, Zinsmeister AR Talley NJ. Can symptoms predict endoscopic findings in GERD? Gastrointest Endosc 2003; 58: 661–70.
  • Reid BJ, Blount PL, Feng Z et al. Optimizing endoscopic biopsy detection of early cancers in Barrett's high-grade dysplasia. Am J Gastroenterol 2000; 95: 3089–96.
  • Sharma P, Dent J, Armstrong D et al. The development and validation of an endoscopic grading system for Barrett's oesophagus: The Prague C & M Criteria. Gastroenterol 2006; 131: 1392–99.
  • Lagergren J, Bergstrom R, Lindgren A et al. Symptomatic gastro-esophageal reflux as a risk factor for esophageal adenocarcinoma. N Engl J Med 1999; 340: 825–31.
  • El-Serag HB, Sonnenberg A. Comorbid occurrence of laryngeal or pulmonary disease with esophagitis in United States military veterans. Gastroenterol 1997; 113: 755–60.
  • Field SK, Sutherland LR. Does medical antireflux therapy improve asthma in asthmatics with gastroesophageal reflux? A critical review of the literature. Chest 1998; 114: 275–83.
  • Field SK. The effects of antireflux surgery on asthmatics with gastroesophageal reflux. Chest 1999; 116: 766–74g.
  • Harding S, Kiljander T, Field S et al. Efficacy of esomeprazole 40m twice daily for 16 weeks in adults with asthma: A randomized placebo-controlled trial. Gastroenterology 2005;128 (suppl 2): A–61.